Search Results for 'patients response'
patients response published presentations and documents on DocSlides.
When can we use combination therapy for our pediatric IBD p
by pasty-toler
Athos Bousvaros MD, MPH. Advances in IBD Dec 2014...
Haematology and Palliative care
by celsa-spraggs
Lisa Newton. Bradford Teaching Hospitals NHS Foun...
How I treat acquired aplastic anemia
by karlyn-bohler
Blood 2012. Until the 1970s, . (. SAA) was almost...
C-Reactive Protein: a Prognosis Factor for Septic Patient
by olivia-moreira
. Systematic Review and Meta-analysis. Introduct...
Electroconvulsive Therapy and other
by giovanna-bartolotta
Neurostimulation. Techniques. Dr. Patrick Clarke...
Integrated Cancer Treatment and Research Centre
by phoebe-click
Wagholi. , Pune, INDIA. Recognized as . “Center...
Update on Follicular Lymphoma:
by alexa-scheidler
Contemporary Treatment Strategies and Optimal Seq...
Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
by stefany-barnette
Renato G. Martins, MD, MPH. Medical Director, Tho...
Update on Follicular Lymphoma:
by tatiana-dople
Contemporary Treatment Strategies and Optimal Seq...
North West Coast Palliative and End of Life Care Network
by jane-oiler
Audit Meeting. . 15/09/2016. Cancer Associated H...
Severe depression is a public health priority due to its as
by liane-varnes
disability. It is estimated that 16.6. % of the p...
Immunizations in the Immunocompromised
by cheryl-pisano
Traveler. Â . Dr. . Lynora. . Saxinger. Thanks ...
Michelle Boisen , MD Assistant professor of Gynecologic oncology
by calandra-battersby
Magee-. Womens. Hospital of UPMC. Clinical and R...
Overall survival and safety experience from an expanded access program (EAP) of nivolumab (NIVO) fo
by olivia-moreira
Milton Barros e Silva,. 1. Rafael Schmerling,. 2...
Integrated Cancer Treatment and Research Centre
by lois-ondreau
Wagholi. , Pune, INDIA. Recognized as . “Center...
11/03/14 Personalized Approach in Acute and Chronic Leukemias
by kittie-lecroy
Emmanuel C. Besa, M.D.. Professor of Medical Onco...
Btk inhibition in Mantle cell Lymphoma & CLL
by test
Simon Rule. Professor of Clinical . Haematology. ...
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by conchita-marotz
ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....
1 EMS-administered naloxone and patient outcomes in Hawaii:
by ellena-manuel
Findings from a linked dataset. Dan Galanis, Ph.D...
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,
by marina-yarberry
Niraparib. and . Temozolomide. in Patients with...
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive p
by pasty-toler
tumours. and . carcinomas. . European Journal o...
Meet The Professors Hodgkin Lymphoma 2018
by conchita-marotz
Hodgkin Lymphoma (HL) by the Numbers. Optimal Upf...
Patient Selection for PARP
by sherrill-nordquist
Inhibitors:. Purpose and Practicalities . Present...
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
Carfilzomib , Rituximab and Dexamethasone (
by mindeeli
CaRD. ) Is Highly . Active and . Offers a Neuropat...
MM-005: A Phase 1, Multicenter, Open-Label, Dose-Escalation Study
by chiquity
to . Determine the Maximum Tolerated Dose for the ...